Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periocular and intracameral drug strategies to prevent macular edema after cataract surgery
NL-OMON54515Phase 3Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bromfenac sodium, dexamethasone sodium phosphate, triamcinolone acetonide, phenylephrine + ketorolac, ketorolac and 1 more, sponsored by Maastricht University Medical Center+. Started Oct 2021; status: completed.
02
Drugs
bromfenac sodiumdexamethasone sodium phosphatetriamcinolone acetonidephenylephrine + ketorolacketorolac
Beyond the preview
Go deeper on NL-OMON54515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54515.